Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physiological Iron Maintenance in End Stage Renal Disease (ESRD) Subjects by Delivery of Soluble Ferric Pyrophosphate (SFP) Via Hemodialysate: The PRIME Study

NCT01286012 is registered in ClinicalTrials.gov with Rockwell Medical Technologies, Inc. as lead sponsor.

NCT NCT01286012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01286012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physiological Iron Maintenance in End Stage Renal Disease (ESRD) Subjects by Delivery of Soluble Ferric Pyrophosphate (SFP) Via Hemodialysate: The PRIME Study
Lead sponsor
Rockwell Medical Technologies, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2011
Completion date
January 31, 2013
Enrollment
108 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease